Literature DB >> 8326807

[Enzyme liberation and activation of the kallikrein-kinin system in experimental pancreatitis. Studies of portal vein blood, pancreatic lymph and peritoneal effusion].

H Waldner1, B Vollmar, P Conzen, A Götz, P Lehnert, E Fink, W Brendel, L Schweiberer.   

Abstract

The clinical course of acute pancreatitis is strongly influenced by secondary cardiac, pulmonary and renal damage. The aim of the present study was to gather information about the compartment promoting the systemic damage. Therefore the activity of lipase, phospholipase A and plasma pro-kallikrein and the concentration of tissue kallikrein and kininogen were measured in portal venous blood, pancreatic lymph and peritoneal exudate. Anaesthetized pigs were subjected to fluid resuscitation to keep systemic haemodynamic parameters constant. The pancreas was isolated in situ. The pigs were randomly assigned to a control group (n = 9) or one of the two pancreatitis groups (n = 10 each). Pancreatitis was induced by i.a. infusion of free fatty acid (FFS) or retrograde infusion of 5% sodium taurocholate intraductally (NaT). In both pancreatitis groups the activity of lipase and phospholipase A increased. The most pronounced changes were seen in the peritoneal exudate (phospholipase A activity 40 min after induction: control 10.0 U/l, NaT 72.2 U/l). In both pancreatitis groups there was evidence for activation of the tissue kallikrein kinin system in the form of an increase in the kallikrein concentration and a decrease in the kininogen concentration. Again the changes were most pronounced in the peritoneal exudate (tissue kallikrein 40 min after induction: control 14.7 ng/ml, NaT 452 ng/ml).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8326807     DOI: 10.1007/bf00184465

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  19 in total

1.  [MICROMETHOD FOR THE DETERMINATION OF PANCREATIC LIPASE IN THE BLOOD SERUM].

Authors:  H WEBER
Journal:  Dtsch Med Wochenschr       Date:  1965-06-25       Impact factor: 0.628

2.  Studies on the plasma kallikrein-kinin system in peritoneal exudate and plasma during experimental acute pancreatitis in pigs.

Authors:  T E Ruud; A O Aasen; P Kierulf; J Stadaas; S Aune
Journal:  Scand J Gastroenterol       Date:  1985-09       Impact factor: 2.423

3.  Inhibition of plasma kallikrein with aprotinin in porcine endotoxin shock.

Authors:  M Siebeck; E Fink; J Weipert; M Jochum; H Fritz; M Spannagl; P Kroworsch; K Shimamoto; L Schweiberer
Journal:  J Trauma       Date:  1993-02

Review 4.  The role of prostaglandins in acute pancreatitis.

Authors:  G Glazer; E L Gilliland; M A Aldridge
Journal:  Surg Annu       Date:  1987

5.  Hemodynamic consequences of severe pancreatitis.

Authors:  E L Bradley; J R Hall; J Lutz; L Hamner; O Lattouf
Journal:  Ann Surg       Date:  1983-08       Impact factor: 12.969

6.  Release of arachidonic acid metabolites during acute pancreatitis in pigs.

Authors:  B Vollmar; H Waldner; J Schmand; P F Conzen; A E Goetz; H Habazettl; L Schweiberer; W Brendel
Journal:  Scand J Gastroenterol       Date:  1989-12       Impact factor: 2.423

7.  Enzyme transfer from pancreas to plasma during acute pancreatitis. The contribution of ascitic fluid and lymphatic drainage of the pancreas.

Authors:  A D Mayer; M Airey; J Hodgson; M J McMahon
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

8.  Early phase components of the kallikrein kinin system in hemorrhagic ascitic fluid and plasma in the rat with induced acute pancreatitis.

Authors:  W P Seung; B F Feldman
Journal:  Am J Vet Res       Date:  1985-09       Impact factor: 1.156

9.  [Pancreatic circulation in experimental biliary pancreatitis].

Authors:  H Waldner; J Schmand; B Vollmar; A Goetz; P Conzen; L Schweiberer; W Brendel
Journal:  Langenbecks Arch Chir       Date:  1990

10.  Oleic acid induced pancreatitis in pigs.

Authors:  B Vollmar; H Waldner; J Schmand; P F Conzen; A E Goetz; H Habazettl; L Schweiberer; W Brendel
Journal:  J Surg Res       Date:  1991-02       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.